Skip to content

The clinical study on mechanism and treatment of immune abnormality in patients with category III chronic prostatitis

The clinical study on mechanism and treatment of immune abnormality in patients with category III chronic prostatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042405
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Category ? chronic prostatitis

Interventions

category ? chronic prostatitis group:Nil
control group:Nil

Sponsors

Shanghai Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for type III chronic prostatitis: 1. Patients who meet the diagnostic criteria of type III prostatitis defined by the National Institutes of health and Chinese guidelines for the diagnosis and treatment of urological diseases; 2. Patients aged 20-50 years; 3. Voluntary patients, and agree to sign the informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria for type III chronic prostatitis were as follows 1. Patients with serious heart, liver, kidney disease, blood disease, tumor, psychosis, etc; 2. Patients with prostate tumor, prostate tuberculosis, acute prostatitis, urethritis, urethral stricture and acute urethral syndrome; 3. Patients with pelvic surgery history within 6 months; 4. Patients with severe physical diseases and systemic failure; 5. Patients taking other drugs for prostate diseases in recent one week.

Design outcomes

Primary

MeasureTime frame
The NIH - CPSI score;Ultrasonography of prostate;prostatic fluid;routine urine test;Inflammatory mediators examination;CD molecular detection;c-reactive protein;analysis of immune-related signal pathway;

Countries

China

Contacts

Public ContactWang Ying

Shanghai Sixth People’s Hospital

sdzbbswangying@163.com+86 15921063837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026